A Fluorescence Lifetime-Based Assay for Protease Inhibitor Profiling on Human Kallikrein 7

被引:22
作者
Doering, Klaus
Meder, Gabriele [1 ]
Hinnenberger, Manuela [1 ]
Woelcke, Julian [1 ]
Mayr, Lorenz M. [1 ]
Hassiepen, Ulrich [1 ]
机构
[1] Novartis Pharma AG, NIBR, Expertise Platform Proteases, CH-4002 Basel, Switzerland
关键词
compound profiling; high-throughput screening; fluorescence lifetime; compound interference; kallikrein; 7; IN-VITRO;
D O I
10.1177/1087057108327328
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fluorescence lifetime is an intrinsic parameter describing the fluorescence process. Changes in the fluorophore's physicochemical environment can lead to changes in the fluorescence lifetime. When used as the readout in biological assays, it is thought to deliver superior results to conventional optical readouts. Hence it has the potential to replace readout technologies currently established in drug discovery such as absorption, luminescence or fluorescence intensity. Here we report the development of an activity assay for human kallikrein 7, a serine protease involved in skin diseases. As a probe, we have selected a blue-fluorescent acridone dye, featuring a remarkably long lifetime that can be quenched by either of the 2 natural amino acids, tyrosine and tryptophan. Incorporating this probe and 1 of the quenching amino acids on either side of the scissile bond of the substrate peptide enables us to monitor the enzymatic activity by quantifying the increase in the fluorescence lifetime signal. A systematic investigation of substrate structures has led to a homogenous, microplate-based, compound profiling assay that yields inhibitory constants down into the single-digit nanomolar range. This type of assay has now been added to our standard portfolio of screening techniques, and is routinely used for compound profiling. ( Journal of Biomolecular Screening 2009: 1-9)
引用
收藏
页码:1 / 9
页数:9
相关论文
共 20 条
[1]   Structural and biochemical characterization of a fluorogenic rhodamine-labeled malarial protease substrate [J].
Blackman, MJ ;
Corrie, JET ;
Croney, JC ;
Kelly, G ;
Eccleston, JF ;
Jameson, DM .
BIOCHEMISTRY, 2002, 41 (40) :12244-12252
[2]   A proteolytic cascade of kallikreins in the stratum corneum [J].
Brattsand, M ;
Stefansson, K ;
Lundh, C ;
Haasum, Y ;
Egelrud, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (01) :198-203
[3]   Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7 [J].
Caubet, C ;
Jonca, N ;
Brattsand, M ;
Guerrin, M ;
Bernard, D ;
Schmidt, R ;
Egelrud, T ;
Simon, M ;
Serre, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (05) :1235-1244
[4]  
COMLEY J, 2003, DRUG DISCOV WORL SUM, P91
[5]   Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences [J].
Debela, Mekdes ;
Magdolen, Viktor ;
Schechter, Norman ;
Valachova, Martina ;
Lottspeich, Friedrich ;
Craik, Charles S. ;
Choe, Youngchool ;
Bode, Wolfram ;
Goettig, Peter .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) :25678-25688
[6]   Fluorogenic substrates for proteases based on intramolecular fluorescence energy transfer (IFETS) [J].
Gershkovich, A ;
Kholodovych, VV .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1996, 33 (03) :135-162
[7]   2-(diethylamino)thieno[1,3]oxazin-4-ones as stable inhibitors of human leukocyte elastase [J].
Gütschow, M ;
Kuerschner, L ;
Neumann, U ;
Pietsch, M ;
Löser, R ;
Koglin, N ;
Eger, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) :5437-5447
[8]   Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase [J].
Gütschow, M ;
Neumann, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (10) :1729-1740
[9]   Nanosecond time-resolved fluorescence protease assays [J].
Hennig, Andreas ;
Roth, Doris ;
Enderle, Thilo ;
Nau, Werner M. .
CHEMBIOCHEM, 2006, 7 (05) :733-737
[10]  
Jaeger S., 2003, Current Pharmaceutical Biotechnology, V4, P463